Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
6 results
Language : Français
Active substance : alemtuzumab
OK
Chercher
Filter
Topic
Diseases and conditions
(6)
Plus ...
Infectious diseases
(2)
Plus ...
Virus diseases
(1)
Parasitic diseases and mycoses
(1)
Blood and lymphatic diseases
(2)
Plus ...
Bone marrow diseases
(1)
Anemia and hemoglobinopathies
(1)
Hematologic cancers
(1)
Immune system diseases
(2)
Plus ...
Autoimmune diseases
(1)
Immunologic deficiency syndromes
(1)
Respiratory tract diseases
(1)
Plus ...
Pulmonary and pleural diseases
(1)
Nervous system diseases
(1)
Plus ...
Central nervous system diseases
(1)
Demyelinating diseases
(1)
Congenital, genetic and rare diseases
(1)
Cancers - miscellaneous
(1)
Diagnostic and therapeutic techniques
(5)
Plus ...
Drug therapy
(3)
Vaccine
(1)
Diagnostic techniques and procedures
(1)
Plus ...
Biology (laboratory tests)
(1)
Economics and public health
(2)
Plus ...
Organisation of care
(1)
Health economics
(1)
Content type
Drugs, devices and medical acts
(3)
Plus ...
Medicine
(2)
Health technology assessment
(1)
Practice Guidelines and Other Guides
(3)
Plus ...
Practice guidelines
(1)
Chronic disease guide
(1)
Public Health guideline
(1)
Date
Last five years
(1)
This year
(1)
Manufacturer
inconnu
(1)
industriels
(1)
Language
Français
(6)
Active substance
aciclovir
(2)
acide folique
(1)
adalimumab
(1)
alcool
(1)
alemtuzumab
(6)
allopurinol
(1)
amitriptyline
(1)
amoxicilline
(1)
atovaquone
(2)
azathioprine
(3)
basiliximab
(1)
busulfan
(1)
carbimazole
(1)
chloroquine
(1)
chlorpropamide
(1)
chlorure de sodium
(1)
ciclosporine
(2)
ciprofloxacine
(2)
cisplatine
(1)
cyclophosphamide
(4)
cytarabine
(1)
danazol
(1)
dapsone
(1)
eltrombopag
(1)
famciclovir
(1)
fer
(2)
fibronectine
(1)
gabapentine
(1)
gemcitabine
(1)
ifosfamide
(1)
infliximab
(1)
itraconazole
(1)
leucine
(1)
oxaliplatine
(1)
paclitaxel
(1)
pentostatine
(1)
phosphate
(1)
piroxicam
(1)
posaconazole
(1)
prednisolone
(2)
prednisone
(2)
rifampicine
(1)
rituximab
(3)
romiplostim
(1)
sirolimus
(2)
sulfasalazine
(1)
tacrolimus
(1)
trastuzumab
(1)
valaciclovir
(2)
voriconazole
(1)
More filter
Save your search
Practice guidelines and other guides
- 3 results
Shingles vaccination recommendations and the role of the Shingrix vaccine
Public Health guideline
- Posted on 7/3/2024
Download
abstract
Add to
my selection
Acquired and inherited aplastic anemia
Chronic disease guide
- Posted on 4/5/2024
Download
guide
Add to
my selection
Patient selection criteria for at-home cancer chemotherapy
Practice guidelines
- Posted on 1/9/2003 - Mis à jour le 30/10/2006
Download
abstract
Add to
my selection
Drugs, devices and medical acts
- 3 results
LEMTRADA
Medicine
- Posted on 25/10/2018 - Mis à jour le 12/6/2019
Add to
my selection
MABCAMPATH (alemtuzumab)
Medicine
- Posted on 17/9/2009 - Mis à jour le 12/6/2019
Add to
my selection
Assessment of biological tests for Pneumocystis Pneumonia (Pneumocystis jirovecii infections) diagnosis - INAHTA Brief
Health technology assessment
- Posted on 18/10/2017
Download
document
Add to
my selection
Français
English
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
FV7KxfTNcfqkLG1e